ππ§ Wetin Psychedelic Therapy Suppose Be Like? π
As MDMA and psilocybin treatments dey become popular, people don begin dey look as e dey important to scrutinize di therapy side. Here na wetin dey common for many sessions β and wetin no dey there. π§
Psychedelic therapy dey waka enter mainstream medical treatment for mental health care. In 2020 and 2022, residents of Oregon and Colorado vote say make dem legalize the use of psilocybin π, the psychoactive ingredient wey dey make person hallucinate from mushrooms π, and di Food and Drug Administration dey expect to approve am with MDMA, or Ecstasy π, to treat depression and post-traumatic stress disorder by 2024.
While people dey show evidence say psychedelics fit provide better treatment for mental illness wey stubborn wella, people dey talk of stories wey concern abuse or trauma π«π wey e get to do with therapists pass di drugs.
Some cases involve clear example of sexual assault π«π ββοΈ. For some oda cases, di therapist fit get good intention but still cause harm instead of healing π. For one recent clinical trial, wey show say psilocybin fit bring relief to people wey dey struggle with depression, three participants talk say dem get thoughts to kill themselves and even harm demself for di weeks wey follow di therapy π¨π.
For 20 years, research don help to standardize di dosage of di drugs wey dey use for clinical trials, but di therapy part no dey receive di same attention. Instead, wetin therapists dey do dey mostly based on tradition instead of empirical evidence, Dr. Charles Raison talk, wey be di director of clinical and translational research for Usona Institute for Wisconsin and a professor of psychiatry for University of Wisconsin. π§ͺπ¨ββοΈπ
Di fact say people never support di best practices wey scientists don approve don make researchers, clinicians, and people wey don receive treatment before dey call for make dem take serious look at di therapeutic side of psychedelic therapy. π₯π¬π
βI dey very concerned about di ways wey well-meaning therapists fit dey do harm,β Sarah McNamee talk, wey be licensed psychotherapist and research coordinator for School of Social Work for McGill University. πππ
Because people dey very vulnerable emotionally when dem dey on top psychedelics, e dey very risky make person wey no sabi wetin e dey do dey treat dem. βE fit easy make person condition worsen,β Janis Phelps talk, wey be director of Center for Psychedelic Therapies and Research for California Institute of Integral Studies wey dey offer psychology and counseling degrees. ππ°π ββοΈ
Here na wetin dey happen for many psychedelic therapy sessions and wetin fit show say sometin dey wrong. π
How to Choose Therapist π€π₯ For most places, di only legal way wey person fit try psychedelic therapy wey use psilocybin or MDMA na if dem enroll for clinical trial. (Dem dey fit give ketamine for clinics or e fit even send am give you for house, but experts dey strongly advise say make e dey use only for combination with therapy.) ππ₯
Di person wey you go work with suppose be mental health professional, wey better if e specialize for your condition and e suppose don get certification for psychedelic therapy, wey get many training programs now. Amy Lehrner, wey be clinical director for Center for Psychedelic Psychotherapy and Trauma Research for Icahn School of Medicine for Mount Sinai, recommend say people make dem check di person wey wan treat dem wella, na im e talk say make dem check di person training, professional certifications and expertise. π§ββοΈπβ
Oda options wey dey underground don dey explore psychedelic therapy, but dem no dey legal or regulated, so e fit pose risk to safety and effectiveness. π«β οΈ
Make sure say you prioritize your safety and choose wisely when exploring psychedelic therapy. πππ
NOW IN ENGLISH
ππ§ What Should Psychedelic Therapy Be Like? π
As MDMA and psilocybin treatments gain popularity, it’s becoming important to scrutinize the therapy aspect. Here’s what’s common in many sessionsβand what’s missing. π§
Psychedelic therapy is making its way into mainstream medical treatment for mental health care. In 2020 and 2022, residents of Oregon and Colorado voted to legalize the use of psilocybin π, the psychoactive ingredient that makes people hallucinate from mushrooms π. The Food and Drug Administration is expected to approve it, along with MDMA or Ecstasy π, to treat depression and post-traumatic stress disorder by 2024.
While there is evidence that psychedelics can provide better treatment for stubborn mental illnesses, there are stories of abuse or trauma π«π related to therapists rather than the drugs themselves.
Some cases involve clear examples of sexual assault π«π ββοΈ. In other cases, the therapist may have good intentions but end up causing harm instead of healing π. In a recent clinical trial that showed psilocybin could bring relief to people struggling with depression, three participants reported having thoughts of suicide and self-harm in the weeks following the therapy π¨π.
While research has helped standardize the dosage of drugs used in clinical trials over the past 20 years, the therapy aspect has not received the same level of attention. Instead, therapists often rely on tradition rather than empirical evidence, according to Dr. Charles Raison, the director of clinical and translational research at the Usona Institute and a professor of psychiatry at the University of Wisconsin. π§ͺπ¨ββοΈπ
The lack of support for approved best practices has prompted researchers, clinicians, and individuals who have undergone treatment to call for a serious examination of the therapeutic side of psychedelic therapy. π₯π¬π
“I am very concerned about the ways well-meaning therapists can do harm,” said Sarah McNamee, a licensed psychotherapist and research coordinator at the School of Social Work at McGill University. πππ
Because people are emotionally vulnerable when on psychedelics, it is risky to have someone who doesn’t know what they’re doing treat them. “It can easily worsen a person’s condition,” said Janis Phelps, the director of the Center for Psychedelic Therapies and Research at the California Institute of Integral Studies, which offers psychology and counseling degrees. ππ°π ββοΈ
Here’s what often happens in many psychedelic therapy sessions, which may indicate something is amiss. π
How to Choose a Therapist π€π₯ In most places, the only legal way to try psychedelic therapy using psilocybin or MDMA is by enrolling in a clinical trial. (Ketamine can be administered in clinics or even at home, but experts strongly advise its use only in combination with therapy.) ππ₯
The person you work with should be a mental health professional who specializes in your condition and has certification in psychedelic therapy, which now has many training programs available. Amy Lehrner, the clinical director for the Center for Psychedelic Psychotherapy and Trauma Research at the Icahn School of Medicine at Mount Sinai, recommends that people thoroughly check the credentials, training, professional certifications, and expertise of the therapist they choose. π§ββοΈπβ
There are other underground options exploring psychedelic therapy, but they are not legal or regulated, posing risks to safety and effectiveness. π«β οΈ
Make sure you prioritize your safety and choose wisely when exploring psychedelic therapy. πππ